{"ticker": {"uuid": "1cb3fb73-2e3a-4930-bde6-9b6bdca9f259", "symbol": "4597", "name": "Solasia Pharma K.K.", "exchange": "JPX", "country": "JP", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "Isofol reaches new phase Ib/II milestones in Europe \u2013 prepares Japanese study with Solasia", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxOQ2xnQ19oeUZCZmVCQVFZRHRZd3FabTQwcnR2VE5US1RWbkZ3QklCVzNEWkl5SDRHcGVoUlZaLWlmT3hOVHF5OFpqRmhYckhCLVNtWUw0djZEVlJxM2plM3NoQUU5MjBVYkRvbE92d2ZNWWF0YzhiSHYzOW9xU1h0UVVTWm94M2wzdnh5VXp2Skpvc1p1OU1ROU1PRW1pcjFwUUV0RjdybjlKYWJtWklnZ0c0UUdFMFlhVG1sNDRMWDJRdw?oc=5", "source_name": "Biostock", "published_at": "2025-11-13T08:00:00+00:00", "published_display": "13 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Solasia: a journey of developing high-quality pharmaceuticals for cancer patients.", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxORDVCSy1fZk1PdWFWNTNDam5DVWd6NFVDM2NmR2NweFBOY0NOMDhlbC1ZMWhjYjFEcFZZcWpNZ2ZhUGxQVWVuWWptLUVFN1Bydm10elpTUXk0Sjk2MEktN2thTHFsYWhXMXZDQV9fNlpIR2dPNENJZWhKa2tpS1VVQ3VpNDExcEIzOEV5bmdKQUhWSEhoaXN1dFJjQmJFeVl2ZmhwVThfMkNUdnVDcHFFMVJsZmxNczQ4VlFUejAyV1Jldw?oc=5", "source_name": "The Worldfolio", "published_at": "2023-09-13T07:00:00+00:00", "published_display": "13 Sep 2023 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Solasia Announces Launch of Darvias\u00ae in Japan", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxPdzlUanU2OWtsVzJHa05lMzFfT2Vpc1FXblpybFR2YkZaQWZodGxkSGxzVmhuLUMtRW1xS1kzeUJ0M3I1dkZPMW5LMTZuOEx2OXBBdHZQcEVxaXJ3X2l1VERiNjJVQnh3WmFYV2hrR0tuSnZTbjlRVVQ4RnQxeno2RHROdnRRTDNsMVE0ZHpDQjBUM1F6RnJFc2x3dmdGVTJaRVlF?oc=5", "source_name": "Business Wire", "published_at": "2022-08-22T07:00:00+00:00", "published_display": "22 Aug 2022 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Solasia Pharma: DARVIAS\u00ae Injection 135mg (Generic Name: DARINAPARSIN /Development Code: SP-02) Approved in Japan", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-gFBVV95cUxOWE5HRFhDMXcwcGtGVkJ2TWdzSm1WOGt2WnAzVTNaYk91RmVHN3BYR2dVR3Joa1lvOGtGakxYdkdwN0I4OFd2SkJEQ1RxOHpSdFd1RTlMTU5SZnc5RXp3MFU0TVYtcFJLU3Y0OFZYMDNla2hSbEdzb1I4elFrbHNQVXI0aHBpZVdTZVZwdGMxRFg3MUd3cy1UQXpVRXBOdk1Hc0xWdldqMEltR0dtSG1oZ2FRUWZwWmJlSU5zejg3RVRXMTFoNnZiOGdfWXQ5U1Rvc0J1RGstWVFZa09rdEhialFHNl9sNnNOWVpaNU1aSW9GVF9uZUh6V1p3?oc=5", "source_name": "STT Info", "published_at": "2022-06-20T07:00:00+00:00", "published_display": "20 Jun 2022 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Isofol reaches new phase Ib/II milestones in Europe \u2013 prepares Japanese study with Solasia", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxOQ2xnQ19oeUZCZmVCQVFZRHRZd3FabTQwcnR2VE5US1RWbkZ3QklCVzNEWkl5SDRHcGVoUlZaLWlmT3hOVHF5OFpqRmhYckhCLVNtWUw0djZEVlJxM2plM3NoQUU5MjBVYkRvbE92d2ZNWWF0YzhiSHYzOW9xU1h0UVVTWm94M2wzdnh5VXp2Skpvc1p1OU1ROU1PRW1pcjFwUUV0RjdybjlKYWJtWklnZ0c0UUdFMFlhVG1sNDRMWDJRdw?oc=5", "source_name": "Biostock", "published_at": "2025-11-13T08:00:00+00:00", "published_display": "13 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Solasia: a journey of developing high-quality pharmaceuticals for cancer patients.", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxORDVCSy1fZk1PdWFWNTNDam5DVWd6NFVDM2NmR2NweFBOY0NOMDhlbC1ZMWhjYjFEcFZZcWpNZ2ZhUGxQVWVuWWptLUVFN1Bydm10elpTUXk0Sjk2MEktN2thTHFsYWhXMXZDQV9fNlpIR2dPNENJZWhKa2tpS1VVQ3VpNDExcEIzOEV5bmdKQUhWSEhoaXN1dFJjQmJFeVl2ZmhwVThfMkNUdnVDcHFFMVJsZmxNczQ4VlFUejAyV1Jldw?oc=5", "source_name": "The Worldfolio", "published_at": "2023-09-13T07:00:00+00:00", "published_display": "13 Sep 2023 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Solasia Announces Launch of Darvias\u00ae in Japan", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxPdzlUanU2OWtsVzJHa05lMzFfT2Vpc1FXblpybFR2YkZaQWZodGxkSGxzVmhuLUMtRW1xS1kzeUJ0M3I1dkZPMW5LMTZuOEx2OXBBdHZQcEVxaXJ3X2l1VERiNjJVQnh3WmFYV2hrR0tuSnZTbjlRVVQ4RnQxeno2RHROdnRRTDNsMVE0ZHpDQjBUM1F6RnJFc2x3dmdGVTJaRVlF?oc=5", "source_name": "Business Wire", "published_at": "2022-08-22T07:00:00+00:00", "published_display": "22 Aug 2022 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Solasia Pharma: DARVIAS\u00ae Injection 135mg (Generic Name: DARINAPARSIN /Development Code: SP-02) Approved in Japan", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-gFBVV95cUxOWE5HRFhDMXcwcGtGVkJ2TWdzSm1WOGt2WnAzVTNaYk91RmVHN3BYR2dVR3Joa1lvOGtGakxYdkdwN0I4OFd2SkJEQ1RxOHpSdFd1RTlMTU5SZnc5RXp3MFU0TVYtcFJLU3Y0OFZYMDNla2hSbEdzb1I4elFrbHNQVXI0aHBpZVdTZVZwdGMxRFg3MUd3cy1UQXpVRXBOdk1Hc0xWdldqMEltR0dtSG1oZ2FRUWZwWmJlSU5zejg3RVRXMTFoNnZiOGdfWXQ5U1Rvc0J1RGstWVFZa09rdEhialFHNl9sNnNOWVpaNU1aSW9GVF9uZUh6V1p3?oc=5", "source_name": "STT Info", "published_at": "2022-06-20T07:00:00+00:00", "published_display": "20 Jun 2022 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 62, "total_relevant": 4, "sentiment_summary": {"positive": 0, "negative": 0, "neutral": 4, "score": 50, "total": 4, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 80, "events": [{"event": "general", "label": "Market update", "weight": 2.2, "count": 4}], "positive_events": 0, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 26.0, "latest_week": "2026-07-10", "one_week_move": 0.0, "four_week_move": 13.0, "twelve_week_move": -31.6, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.60972, "market_dynamics_buy_signal": false, "relative_strength": -40.089202, "fair_value_gap": -29.7, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 40.3885, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "+0.0% over one week, +13.0% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 48, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Biostock", "count": 1}, {"label": "The Worldfolio", "count": 1}, {"label": "Business Wire", "count": 1}, {"label": "STT Info", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 4}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 4}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "80/100 classification confidence."}, {"label": "Company focus", "value": "4", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+0.0% over one week, +13.0% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Isofol reaches new phase Ib/II milestones in Europe \u2013 prepares Japanese study with Solasia"}], "updated_at": "2026-07-17T09:10:21.672549+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}